Participants
psychiatric disorder, bipolar disorder, cognitive impairment, psychosis
DISORDER
Patients at Liljeholmen Primary Health Care Center with a primary diagnosis of GAD were invited to participate. Patients were excluded from the study if they were younger than 18 years; unable to speak Swedish; or had a severe psychiatric disorder (e.g., psychosis, bipolar disorder), cognitive impairment, substance use disorder, or other ongoing psychological treatment. Patients who had initiated or altered a psychopharmaceutical prescription less than six weeks prior to study inclusion were also excluded.Because assessing treatment effectiveness was not a primary aim, a power calculation was not conducted, but a goal of recruiting at least 50 participants was set to enable us to assess feasibility and preliminary effectiveness.